The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis

Clinical and Experimental Metastasis

Volumn 27, Issue 5, 2010, Pages 361-369

  Weng, Chia Jui ^a   Yen, Gow Chin ^b  

^a TAINAN UNIVERSITY OF TECHNOLOGY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Anti invasion; Anti metastasis; Ganoderma lucidum; Polysaccharides; Triterpenoids

Indexed keywords

BETA1 INTEGRIN; GANODERMA LUCIDUM EXTRACT; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE; UROKINASE RECEPTOR; VASCULOTROPIN; PLANT EXTRACT;

ANTINEOPLASTIC ACTIVITY; CANCER INVASION; CANCER PREVENTION; CELL LINE; CHEMOPROPHYLAXIS; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; GANODERMA LUCIDUM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; ANIMAL; CHEMISTRY;

ANIMALS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PLANT EXTRACTS; REISHI;

EID: 77953924040     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-010-9334-z     Document Type: Review

References (79)

1. L Weiss 1990 Metastatic inefficiency Adv Cancer Res 54 159 211 10.1016/S0065-230X(08)60811-8 1:STN:280:DyaK3c7hvFSisw%3D%3D 1688681 (Pubitemid 20088338)
2. LA Liotta PS Steeg WG Stetter-Stevenson 1991 Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation Cell 64 327 336 10.1016/0092-8674(91)90642-C 1:CAS:528:DyaK3MXpvFWktA%3D%3D 1703045
3. J Condeelis JE Segall 2003 Intravital imaging of cell movement in tumours Nat Rev Cancer 3 921 930 10.1038/nrc1231 1:CAS:528:DC%2BD3sXpvFahsLc%3D 14737122 (Pubitemid 37500177)
4. D Sliva 2008 Suppression of cancer invasiveness by dietary compounds Mini Rev Med Chem 8 677 688 10.2174/138955708784567412 1:CAS:528: DC%2BD1cXnslWkurw%3D 18537723
5. M Aarisawa A Fujita M Saga, et al. 1986 Three new lanostanoids from Ganoderma lucidum J Nat Prod 49 621 625 10.1021/np50046a010 (Pubitemid 16001135)
6. YH Gao SF Zhou 2004 Chemopreventive and tumoricidal properties of Ling Zhi mushroom Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae). II. Mechanism considerations Int J Med Mushrooms 6 219 230 10.1615/IntJMedMushr. v6.i3.20 1:CAS:528:DC%2BD2cXos1ems7g%3D
7. JJ Gao N Nakamura BS Min, et al. 2004 Quantitative determination of bitter principles in specimens of Ganoderma lucidum using high-performance liquid chromatography and its application to the evaluation of Ganoderma products Chem Pharm Bull 52 688 695 10.1248/cpb.52.688 1:CAS:528: DC%2BD2cXltFKqs7o%3D 15187388 (Pubitemid 41685505)
8. ZB Lin HN Zhang 2004 Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms Acta Pharmacol Sin 25 1387 1395 1:CAS:528:DC%2BD2cXpvVCjsbY%3D 15525457 (Pubitemid 39490882)
9. N Johnston 2005 Medicinal mushroom cuts off prostate cancer cells' blood supply Drug Discov Today 10 23 24 10.1016/S1359-6446(04)03294-5 (Pubitemid 40164816)
10. GQ Liu KC Zhang 2005 Mechanisms of the anticancer action of Ganoderma lucidum (Leyss. Ex Fr.) Karst.: A new understanding J Integr Plant Biol 47 129 135 10.1111/j.1744-7909.2005.00037.x 1:CAS:528:DC%2BD28Xpt1ymtw%3D%3D (Pubitemid 41029910)
11. JWM Yuen MDI Gohel 2005 Anticancer effects of Ganoderma lucidum: a review of scientific evidence Nutr Cancer 53 11 17 10.1207/s15327914nc5301-2 1:CAS:528:DC%2BD28XptF2ksQ%3D%3D 16351502 (Pubitemid 43068549)
12. RR Paterson 2006 Ganoderma-a therapeutic fungal biofactory Phytochemistry 67 1985 2001 10.1016/j.phytochem.2006.07.004 1:CAS:528:DC%2BD28XptFCgt7k%3D 16905165 (Pubitemid 44301285)
13. JT Xie CZ Wang S Wicks, et al. 2006 Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells Exp Oncol 28 25 29 1:CAS:528:DC%2BD28Xltlakt7o%3D 16614703
14. G Stanley K Harvey V Slivova, et al. 2005 Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-b1 from prostate cancer cells Biochem Biophys Res Commun 330 46 52 10.1016/j.bbrc.2005. 02.116 1:CAS:528:DC%2BD2MXisVCnu7c%3D 15781230 (Pubitemid 40394934)
15. D Sliva D Rizzo 2002 Phosphatidylinositol 3-kinase and NF-κB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator J Biol Chem 277 3150 3157 10.1074/jbc.M109579200 1:CAS:528:DC%2BD38XhtVaks74%3D 11689575 (Pubitemid 34953176)
16. Teow SS (1997) The effective application of Ganoderma nutriceuticals. In: Kim BK, Moon CK, Kim TS (eds) Recent progress in Ganoderma lucidum research. The Pharmaceutical Society of Korea, Seoul
17. YY Wang KH Khoo ST Chen, et al. 2002 Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi). Polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities Bioorgan Med Chem 10 1057 1062 10.1016/S0968-0896(01)00377-7 1:CAS:528:DC%2BD38XhtVKhsbg%3D (Pubitemid 34139921)
18. HL Yang KC Zhang 2002 The relationship between molecular structure and activity of Ganoderma acids J Wuxi Univ Light Ind 21 249 253 1:CAS:528:DC%2BD38XptFSiu74%3D (in Chinese with an English abstract)
19. Ooi VE, Liu F (2000) Immunomodulation and anti-cancer activity of polysaccharideprotein complexes. Curr Med Chem 7:715-729 (Pubitemid 30366638)
20. Wasser SP (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60: 258-274 (Pubitemid 35352092)
21. R Sullivan JE Smith NJ Rowan 2006 Medicinal mushrooms and cancer therapy: translating a traditional practice into western medicine Perspect Biol Med 49 159 170 10.1353/pbm.2006.0034 1:CAS:528:DC%2BD28XkvF2nsL0%3D 16702701
22. M Zhang SW Cui PCK Cheung, et al. 2007 Antitumor polysaccharides from mushrooms: a review of their isolation process, structural characteristics and antitumor activity Trends Food Sci Tech 18 4 19 10.1016/j.tifs.2006.07.013 (Pubitemid 44827599)
23. JW Hyun EC Choi BK Kim 1990 Studies on constituents of higher fungi of Korea IXII. Antitumor components of the basidiocarp of Ganoderma lucidum Korean J Mycol 18 58 69 1:CAS:528:DyaK3MXhs1Sgu7g%3D
24. TS Wu LS Shi SC Kuo 2001 Cytotoxicity of Ganoderma lucidum triterpenes J Nat Prod 64 1121 1122 10.1021/np010115w 1:CAS:528:DC%2BD3MXlsFGls7g%3D 11520245 (Pubitemid 32800357)
25. T Akihisa Y Nakamura M Tagata, et al. 2007 Ani-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum Chem Biodivers 4 224 231 10.1002/cbdv.200790027 1:CAS:528:DC%2BD2sXisVyhu7k%3D 17311233 (Pubitemid 46929192)
26. Y Chen Y Yan MY Xie, et al. 2008 Development of a chromatographic fingerprint for the chloroform extracts of Ganoderma lucidum by HPLC and LC-MS J Pharm Biomed Anal 47 469 477 10.1016/j.jpba.2008.01.039 1:CAS:528: DC%2BD1cXmtlyitr4%3D 18337046
27. MS Shiao 2003 Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions Chem Rec 3 172 180 10.1002/tcr.10058 1:CAS:528:DC%2BD3sXmvVeku7s%3D 12900937 (Pubitemid 38569308)
28. D Sliva 2003 Ganoderma lucidum (Reishi) in cancer treatment Integr Cancer Ther 2 358 364 10.1177/1534735403259066 14713328 (Pubitemid 37444432)
29. D Sliva 2006 Ganoderma lucidum in cancer research Leuk Res 30 767 768 10.1016/j.leukres.2005.12.015 16458355 (Pubitemid 43816705)
30. R Russell M Paterson 2006 Ganoderma-A therapeutic fungal biofactory Phytochemistry 67 1985 2001 10.1016/j.phytochem.2006.07.004 (Pubitemid 44301285)
31. SS Lee YH Wei CF Chen, et al. 1995 Antitumor effects of Ganoderma lucidum J Chin Med 6 1 12
32. Y Nonaka H Ishibashi M Nakai, et al. 2008 Effects of the antlered form of Ganoderma lucidum on tumor growth and metastasis in cyclophosphamide-treated mice Biosci Biotechnol Biochem 72 1399 1408 10.1271/bbb.70607 1:CAS:528:DC%2BD1cXotlylu7c%3D 18540114 (Pubitemid 351883775)
33. AC Allison 2000 Immunosuppressive drugs: the first 50 years and a glance forward Immunopharmacology 47 63 83 10.1016/S0162-3109(00)00186-7 1:CAS:528:DC%2BD3cXktlKkt70%3D 10878284 (Pubitemid 30394533)
34. D Sliva C Labarrere V Slivova, et al. 2002 Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells Biochem Biophys Res Commun 298 603 612 10.1016/S0006-291X(02)02496-8 1:CAS:528:DC%2BD38XotFSns7Y%3D 12408995 (Pubitemid 35333701)
35. D Sliva M Sedlak V Slivova, et al. 2003 Biological activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells J Altern Complement Med 9 491 497 10.1089/107555303322284776 14499024 (Pubitemid 37051539)
36. V Slivova T Valachovicova J Jiang, et al. 2004 Ganoderma lucidum inhibits invasiveness of breast cancer cells J Cancer Integr Med 2 25 30
37. A Thyagarajan J Zhu D Sliva 2007 Combined effect of green tea and Ganoderma lucidum on invasive behavior of breast cancer cells Int J Oncol 30 963 969 1:CAS:528:DC%2BD2sXkt1Whtb4%3D 17332936
38. A Thyagarajan J Jiang A Hopf, et al. 2006 Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion Intl J Mol Med 18 657 664 1:CAS:528:DC%2BD28XhtV2rt7%2FO
39. YS Song SH Kim JH Sa, et al. 2004 Anti-angiogenesis and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum J Ethnopharmacol 90 17 20 10.1016/j.jep.2003.09.006 14698502 (Pubitemid 38091679)
40. JK Zjawiony 2004 Biologically active compounds from Aphyllophorales (Polypore) fungi J Nat Prod 67 300 310 10.1021/np030372w 1:CAS:528: DC%2BD2cXmtFWltg%3D%3D 14987072 (Pubitemid 38282922)
41. SC Jong JM Birmingham 1992 Medicinal benefits of the mushroom Ganoderma Adv Appl Microbiol 37 101 134 10.1016/S0065-2164(08)70253-3 1:CAS:528: DyaK3sXnt12iuw%3D%3D 1642155
42. Shiao MS, Lee KR, Lin LJ et al. (1994) Natural products and biological activities of the chinese medicinal fungus Ganoderma lucidum. In: Ho CT, Osawa T, Huang MT, Rosen RT (eds) Food phytochemicals for cancer prevention II: teas, spices and herbs. Oxford University Press, Washington, DC
43. Y Chen MY Xie XFJ Gong 2007 Microwave-assisted extraction used for the isolation of total triterpenoid saponins from Ganoderma atrum J Food Eng 81 162 170 10.1016/j.jfoodeng.2006.10.018 1:CAS:528:DC%2BD2sXjs1ymu7o%3D (Pubitemid 46176304)
44. T Mizuno G Wang J Zhang, et al. 1995 Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects Food Rev Int 11 151 166 10.1080/87559129509541025 1:CAS:528:DyaK2MXltlKiu7o%3D
45. BS Min JJ Gao N Nakamura, et al. 2000 Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells Chem Pharm Bull 48 1026 1033 1:CAS:528:DC%2BD3cXkslOnsb8%3D 10923835 (Pubitemid 30485402)
46. JK Adam B Odhav KD Bhoola 2003 Immune responses in cancer Food Rev Int 99 113 132 1:CAS:528:DC%2BD3sXksVegsrs%3D (Pubitemid 36700437)
47. QZ Cao ZB Lin 2004 Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide Acta Pharmacol Sin 25 833 838 1:CAS:528:DC%2BD2cXkvVyqtLw%3D 15169641 (Pubitemid 38736114)
48. YH Gao E Chan SF Zhou 2004 Immunomodulating activities of Ganoderma, a mushroom with medicinal properties Food Rev Int 20 123 161 10.1081/FRI-120037158 (Pubitemid 38805931)
49. YH Gao WB Tang H Gao, et al. 2004 Chemopreventive and tumoricidal properties of Lingzhi mushroom Ganoderma lucidum (W. Curt.:Fr.) Lloyd (Aphyllophorophoromycetideae). I. Preclinical and clinical studies (review) Int J Med Mushroom 6 95 106 10.1615/IntJMedMushr.v6.i2.10 1:CAS:528: DC%2BD2cXlvVeqtrY%3D
50. JJ Gao BS Min E Ahn, et al. 2002 New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells Chem Pharm Bull 50 837 840 10.1248/cpb.50.837 1:CAS:528: DC%2BD38XkvFOltLg%3D 12045343 (Pubitemid 41694906)
51. ZB Lin 2005 Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum J Pharmacol Sci 99 144 153 10.1254/jphs.CRJ05008X 1:CAS:528:DC%2BD2MXhtFOns7vM 16230843 (Pubitemid 41524452)
52. X Liu JP Yuan CK Chung, et al. 2002 Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum Cancer Lett 182 155 161 10.1016/S0304-3835(02)00080-0 1:CAS:528:DC%2BD38XktFKgsr0%3D 12048161 (Pubitemid 34621179)
53. 13C-NMR correlation of stereochemistry in lanostanoids triterpenes J Nat Prod 52 595 605 10.1021/np50063a020 1:CAS:528:DyaK3cXnslGl
54. CN Lin WP Tome SJ Won 1990 A lanostanoid of formosan Ganoderma lucidum Phytochemistry 29 673 675 10.1016/0031-9422(90)85145-6 1:CAS:528: DyaK3cXhslGltbg%3D
55. CN Lin WP Tome 1991 Novel cytotoxic principles of formosan Ganoderma lucidum J Nat Prod 54 998 1002 10.1021/np50076a012 1:CAS:528: DyaK38XjslGlug%3D%3D 1791484
56. Y Kimura M Taniguchi K Baba 2002 Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance Anticancer Res 22 3309 3318 1:CAS:528:DC%2BD3sXoslyntw%3D%3D 12530080 (Pubitemid 36070107)
57. DE Kleiner WG Stetler-Stevenson 1999 Matrix metalloproteinases and metastasis Cancer Chemother Pharmacol 43 S41 S51 10.1007/s002800051097
58. J Westermarck VM Kahari 1999 Regulation of matrix metalloproteinase expression in tumor invasion FASEB J 13 781 792 1:CAS:528:DyaK1MXjtFGksrs%3D 10224222 (Pubitemid 29220691)
59. JS Rao 2003 Molecular mechanisms of glioma invasiveness: the role of proteases Nat Rev Cancer 3 489 501 10.1038/nrc1121 1:CAS:528: DC%2BD3sXltVSqtr8%3D 12835669
60. P Basset A Okada MP Chenard, et al. 1997 Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications Matrix Biol 15 535 541 10.1016/S0945-053X(97)90028-7 1:CAS:528: DyaK2sXjsVKisrs%3D 9138286 (Pubitemid 27190028)
61. AR Nelson B Fingleton ML Rothenberg, et al. 2000 Matrix metalloproteinases: biologic activity and clinical implications J Clin Oncol 18 1135 1149 1:CAS:528:DC%2BD3cXitVCgsbg%3D 10694567 (Pubitemid 30123793)
62. TW Chung SK Moon YC Lee, et al. 2002 Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells Arch Biochem Biophys 408 147 154 10.1016/S0003-9861(02)00522-2 1:CAS:528:DC%2BD38XpsF2lu78%3D 12464265 (Pubitemid 36027033)
63. AP Mazar 2001 The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer Anticancer Drugs 12 387 400 10.1097/00001813-200106000-00001 1:CAS:528:DC%2BD3MXlsV2gs7g%3D 11395568 (Pubitemid 32643084)
64. T Ikekawa M Nakanishi N Uehara, et al. 1969 Antitumor activity of aqueous extracts of edible mushrooms Cancer Res 29 734 735 1:STN:280: DyaF1M7jsVSntQ%3D%3D 5813100
65. J Folkman 1989 What is the evidence that tumor are angiogenesis dependent? J Natl Cancer Inst 82 4 6 10.1093/jnci/82.1.4 (Pubitemid 20020880)
66. KJ Kim B Li J Winer, et al. 1993 Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo Nature 362 841 844 10.1038/362841a0 1:CAS:528:DyaK3sXktVKju7s%3D 7683111 (Pubitemid 23132159)
67. B Millauer LK Shawver KH Plate, et al. 1994 Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant Nature 367 576 579 10.1038/367576a0 1:CAS:528:DyaK2cXhs1Sgt7w%3D 8107827 (Pubitemid 2027191)
68. T Miura L Yuan B Sun, et al. 2002 Isoflavone aglycon produced by culture of soybean extracts with basidiomycetes and its anti-angiogenic activity Biosci Biotechnol Biochem 66 2626 2631 10.1271/bbb.66.2626 1:CAS:528: DC%2BD3sXht1Gqug%3D%3D 12596858 (Pubitemid 39251135)
69. QP Wu YZ Xie SZ Li, et al. 2006 Tumor cell adhesion and integrin expression affected by Ganoderma lucidum Enzyme Microb Tech 40 32 41 10.1016/j.enzmictec.2005.10.034 1:CAS:528:DC%2BD28XhtFWitbnL (Pubitemid 44556754)
70. QZ Cao SQ Lin SZ Wang 2007 Effect of Ganoderma lucidum polysaccharides peptide on invasion of human lung carcinoma cells in vitro Beijing Da Xue Xue Bao 39 653 656 1:CAS:528:DC%2BD1MXjtlegsQ%3D%3D 18087562
71. W Tang TY Gu JJ Zhong 2006 Separation of targeted ganoderic acids from Ganoderma lucidum by reversed phase liquid chromatography with ultraviolet and mass spectrometry detections Biochem Eng J 32 205 210 10.1016/j.bej.2006.09.026 1:CAS:528:DC%2BD28Xht1CisLrP (Pubitemid 44751583)
72. G Wang J Zhao JW Liu, et al. 2007 Enhancement of IL-2 and IFN-gamma expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo Int Immunopharmacol 7 864 870 10.1016/j.intimp.2007.02.006 1:CAS:528:DC%2BD2sXkslKqsLc%3D 17466920 (Pubitemid 46635284)
73. NH Chen JW Liu JJ Zhong 2008 Ganoderic acid Me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression J Pharmacol Sci 108 212 216 10.1254/jphs.SC0080019 1:CAS:528:DC%2BD1cXhtlehs7%2FM 18946196
74. J Jiang B Grieb A Thyagarajan, et al. 2008 Ganoderic acid suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling Int J Mol Med 21 577 584 1:CAS:528:DC%2BD1cXmt1amtL4%3D 18425349
75. NH Chen JW Liu JJ Zhong 2010 Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression Pharmacol Rep 62 150 163 20360625
76. CJ Weng CF Chau KD Chen, et al. 2007 The anti-invasive effects of lucidenic acids isolated from a new Ganoderma lucidum strain Mol Nutr Food Res 51 1472 1477 10.1002/mnfr.200700155 1:CAS:528:DC%2BD1cXhsFyqsg%3D%3D 17979098
77. J Jiang V Slivova T Valachovicova, et al. 2004 Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3 Int J Oncol 24 1093 1100 1:CAS:528:DC%2BD2cXjvVGgu7s%3D 15067330
78. CJ Weng CF Chau YS Hsieh, et al. 2008 Lucidenic acid inhibit PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kB and AP-1 Carcinogenesis 29 147 156 10.1093/carcin/bgm261 1:CAS:528:DC%2BD1cXhs1aisb8%3D 18024477 (Pubitemid 351201753)
79. CJ Weng CF Chau GC Yen, et al. 2009 Inhibitory effects of Ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models J Agric Food Chem 57 5049 5057 10.1021/jf900828k 1:CAS:528:DC%2BD1MXlsFKrsLw%3D 19422227